We are live on ! Find out more
GENZ

GENZYME CORP
GENZ

Delisted

GENZ was delisted on the 8th of April, 2011.

Back to rankings

1 hedge funds and large institutions have $3K invested in GENZYME CORP in 2017 Q2 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
1
Holders Change
+1
Holders Change %
–
% of All Funds
0.02%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
NCM
Nelson Capital Management
California
+$3K

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
NCM
1
Nelson Capital Management
California
$3K +$3K +40 New

GENZ Hedge Fund Activity: Q2 2017 in Review

1 of the 4,012 institutional investors tracked by Wall St. Rank reported a position in GENZYME CORP (GENZ) for Q2 2017, worth a combined $3K.

Buyers outnumbered sellers: 1 fund opened new GENZ positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Nelson Capital Management, opening a new position worth an estimated $3K.

  • 1 institutional investor held GENZYME CORP (GENZ) as of Q2 2017, up from 0 in Q1 2017.
  • Funds reported $3K of GENZYME CORP stock for Q2 2017.
  • 1 fund opened new GENZYME CORP positions in Q2 2017 and 0 closed out, a net change of +1 holder.
  • The largest GENZYME CORP buyer in Q2 2017 was Nelson Capital Management, an estimated $3K added.

Based on aggregated 13F filings for Q2 2017.